Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study. — المؤلف: Hachulla, Eric — BioMed research international 20180928

المؤلف
Hachulla, Eric
النشر
BioMed research international 20180928
الوصف
8147251 p.
الموضوعات
Adult؛ Aged؛ Autoimmune Diseases؛ Female؛ France؛ Humans؛ Immunoglobulins, Intravenous؛ Immunologic Deficiency Syndromes